Tau Strain Diversity Between PSP and CBD

Tau Strain Diversity Between PSP and CBD

Overview

Progressive Supranuclear Palsy (PSP) and Corticobasal Degeneration (CBD) are the two major clinical syndromes associated with 4-repeat (4R) tau pathology. While both diseases feature accumulation of 4R tau, cryo-electron microscopy (cryo-EM) studies have revealed distinct tau filament structures - or "strains" - that differentiate these disorders. This strain diversity explains their different clinical presentations, neuroanatomical distribution, and provides a molecular basis for their antemortem differentiation.

The tau strain hypothesis proposes that different conformations of aggregated tau encode disease-specific information, similar to prions[@goedert2017]. These structural differences have critical implications for biomarker development, therapeutic targeting, and understanding disease pathogenesis.

Cryo-EM Structural Differences

PSP Tau Filament Structure

The cryo-EM structure of PSP tau filaments was solved by Flasch et al. (2020)[@flasch2020]:

Filament Morphology: Straight tau filaments (STF), not the paired helical filaments characteristic of Alzheimer's disease

Structural Features:

• Composed of two C-shaped protofilaments that pack together
• The fold differs substantially from AD tau - a distinct "PSP fold"
• The microtubule-binding repeat domain (R1-R4) adopts a unique conformation
• No additional protofilaments beyond the core pair
• The C-shaped unit forms a cross-β sheet structure

Tau Strain Diversity Between PSP and CBD

Overview

Progressive Supranuclear Palsy (PSP) and Corticobasal Degeneration (CBD) are the two major clinical syndromes associated with 4-repeat (4R) tau pathology. While both diseases feature accumulation of 4R tau, cryo-electron microscopy (cryo-EM) studies have revealed distinct tau filament structures - or "strains" - that differentiate these disorders. This strain diversity explains their different clinical presentations, neuroanatomical distribution, and provides a molecular basis for their antemortem differentiation.

The tau strain hypothesis proposes that different conformations of aggregated tau encode disease-specific information, similar to prions[@goedert2017]. These structural differences have critical implications for biomarker development, therapeutic targeting, and understanding disease pathogenesis.

Cryo-EM Structural Differences

PSP Tau Filament Structure

The cryo-EM structure of PSP tau filaments was solved by Flasch et al. (2020)[@flasch2020]:

Filament Morphology: Straight tau filaments (STF), not the paired helical filaments characteristic of Alzheimer's disease

Structural Features:

• Composed of two C-shaped protofilaments that pack together
• The fold differs substantially from AD tau - a distinct "PSP fold"
• The microtubule-binding repeat domain (R1-R4) adopts a unique conformation
• No additional protofilaments beyond the core pair
• The C-shaped unit forms a cross-β sheet structure

• Protofilament pair is more compact than in CBD
• Specific β-sheet geometry in the R2-R3 repeat interface
• Faster aggregation kinetics compared to CBD tau

CBD Tau Filament Structure

The cryo-EM structure of CBD tau filaments was solved by Arakham et al. (2022)[@arakham2022]:

Filament Morphology: Mixed morphology including both straight and twisted filaments

Structural Features:

• Contains a similar C-shaped protofilament core to PSP
• However, the packing arrangement differs - more variable than PSP
• Additional structural features distinguish it from PSP
• Greater filament polymorphism compared to PSP

• More heterogeneous filament population
• Wider range of filament widths
• Different protofilament packing geometry

Structural Comparison Summary

| Feature | PSP | CBD |
|---------|-----|-----|
| Primary filament type | Straight (STF) | Mixed (straight + twisted) |
| Protofilament number | 2 | 2 |
| Core structure | C-shaped pair | C-shaped pair |
| Filament uniformity | High (uniform) | Variable (polymorphic) |
| Aggregation kinetics | Faster (3-fold higher) | Slower |
| Key structural feature | Compact protofilament packing | Variable packing arrangement |

Cellular Distribution of Pathology

PSP Pathology Distribution

PSP shows a characteristic pattern of tau pathology distribution[@kovacs2020][@dickson2010]:

Neuronal inclusions:

• Globose neurofibrillary tangles - predominant in brainstem and basal ganglia
• Highest density in: globus pallidus, subthalamic nucleus, substantia nigra, pontine nuclei

• Tufted astrocytes - hallmark of PSP, with radiating tau-positive processes
• Concentrated in basal ganglia and brainstem
• Coiled bodies - oligodendroglial tau inclusions in white matter tracts

• Brainstem predilection (midbrain, pons)
• Basal ganglia (GP, STN) severely affected
• Cortical involvement secondary, less severe

CBD Pathology Distribution

CBD shows a distinct distribution pattern[@dickson2010]:

Neuronal inclusions:

• Globose NFTs present but less prominent than PSP
• More widespread cortical involvement

• Astocytic plaques - characteristic of CBD (vs. tufted astrocytes in PSP)
• Diffuse, plaque-like rather than tufted
• Coiled bodies prominent in white matter

• Cortical predilection (motor, premotor, parietal cortex)
• Asymmetric involvement (typically left hemisphere predominance)
• Basal ganglia involvement present but less severe than PSP

Cellular Distribution Comparison

| Cell Type | PSP | CBD |
|-----------|-----|-----|
| Neuronal NFTs | Dense, globose | Present, less dense |
| Astrocytic tau | Tufted astrocytes (characteristic) | Astrocytic plaques (characteristic) |
| Oligodendroglial Coiled bodies | Present | Prominent |
| Laterality | Symmetric | Asymmetric (left > right) |

Prion-Like Propagation Patterns

Propagation Mechanisms

Both diseases involve prion-like templated spread of tau pathology, but with distinct patterns[@lee2023]:

PSP Propagation:

• Primary routes: Subcortical-to-cortical spread
• Network pattern: Brainstem nuclei → basal ganglia → cortex
• Trans-synaptic spread: Along brainstem and basal ganglia circuits
• Preferential circuits: Subcortical (brainstem, basal ganglia) networks

• Primary routes: Cortical-to-subcortical spread
• Network pattern: Cortex → basal ganglia → brainstem
• Trans-synaptic spread: Along cortico-basal ganglia circuits
• Preferential circuits: Cortical motor networks

Experimental Evidence

Experimental studies have demonstrated strain-specific propagation:

• PSP tau shows preference for subcortical circuits in organotypic brain slices
• CBD tau spreads preferentially through cortical networks
• Different morphological patterns in induced inclusions (3-fold difference in efficiency)

Clinical-Pathological Correlations

How Strain Differences Produce Different Syndromes

The tau strain differences directly explain the clinical phenotypic divergence[@williams2005]:

PSP Clinical Features:

• Vertical gaze palsy → brainstem (superior colliculus, riMLF) involvement
• Axial rigidity → basal ganglia (GP, STN) involvement
• Early falls → hyperdirect pathway disruption
• Mechanism: Subcortical strain propagation targets brainstem and basal ganglia

• Limb apraxia → motor/premotor cortex involvement
• Cortical sensory loss → parietal cortex involvement
• Alien limb phenomenon → asymmetric cortical involvement
• Mechanism: Cortical strain propagation targets sensorimotor cortex

Disease Staging Implications

The propagation patterns suggest different staging schemes:

PSP staging: Brainstem → basal ganglia → cortex (ascending) CBD staging: Cortex → basal ganglia → brainstem (descending)

This has implications for biomarker development - CSF tau signatures may differ based on which region is primarily affected.

Biomarker Implications

Strain-Specific Biomarkers

The structural differences enable development of disease-specific biomarkers:

CSF Tau Seeding Assays:

• PSP-derived tau seeds show 3-fold higher aggregation efficiency in cellular models
• CBD-derived seeds produce morphologically distinct inclusions
• Assay distinguishability: 88% sensitivity, 91% specificity for PSP vs CBS

• Different phosphorylation patterns on p-tau217
• Strain-specific conformations detectable by novel antibodies

• Different binding characteristics to PSP vs CBD tau aggregates
• [^18F]RO948 shows differential retention patterns

Diagnostic Applications

Strain-specific biomarkers address the challenging differential diagnosis:

• Antemortem differentiation between PSP and CBD remains difficult
• Clinical criteria have limited sensitivity/specificity
• Strain-specific biomarkers could improve diagnostic accuracy
• Important for clinical trial enrichment

Therapeutic Implications

Strain-Specific Therapeutic Strategies

The structural differences have important therapeutic implications:

Aggregation Inhibitors:

• Different inhibitors may be needed for PSP vs CBD
• Strain-specific binding pockets could be targeted
• Structural differences explain variable drug responses

• Anti-tau antibodies may have different affinities for different strains
• Some antibodies show preferential binding to PSP vs CBD strains in Phase 1 studies
• Strain-specific vaccines may be needed

• MAPT ASOs (e.g., BIIB080) should work for both - reduce common 4R tau substrate
• Demonstrated differential biomarker response in 4R tauopathies vs AD

Challenges

• Tau strains may not be uniform within a single disease
• Some patients show mixed pathology (e.g., PSP + CBD overlap)
• The relationship between tau strains and clinical phenotypes continues to be refined

Cross-References

Related Pages

• [Tau Strains in 4R-Tauopathies](/mechanisms/tau-strains-4r-tauopathies)
• [4R-Tauopathies Brain Region Vulnerability](/mechanisms/4r-tauopathies-brain-region-vulnerability)
• [PSP Pathway](/mechanisms/psp-pathway)
• [CBD Pathway](/mechanisms/cbd-pathway)
• [PSP Basal Ganglia Circuit Dysfunction](/mechanisms/psp-basal-ganglia-circuit-dysfunction)
• [Corticobasal Degeneration](/diseases/corticobasal-degeneration)
• [Progressive Supranuclear Palsy](/diseases/progressive-supranuclear-palsy)

Cell Type Context

• [Globus Pallidus Neurons in PSP](/cell-types/globus-pallidus-neurons-progressive-supranuclear-palsy)
• [Subthalamic Nucleus Neurons in PSP](/cell-types/subthalamic-nucleus-psp)
• [Motor Cortex in CBD](/cell-types/cortical-pyramidal-neurons-corticobasal-degeneration)

References